BrightSpring Health Services, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 |
|---|---|---|---|---|
| Revenue | $12.9B | $10.1B | $7.7B | $7.7B |
| Gross profit | $1.5B | $1.3B | $1.1B | $1.4B |
| Operating income | $295.3M | $108.0M | $58.1M | $187.8M |
| Cash from operations | $490.2M | $23.8M | $210.8M | -$4.7M |
| Capital expenditure | $95.5M | $80.9M | $73.5M | $70.1M |
| Free cash flow | $394.7M | -$57.1M | $137.3M | -$74.8M |
| Share repurchases | $43.2M | $650,000 | $650,000 | — |
| Impairments | $0 | $0 | $0 | $40.9M |
| Total assets | $6.4B | $5.9B | $5.5B | — |
| Total liabilities | $4.5B | $4.3B | $4.9B | — |
| Total debt | $2.6B | $2.7B | $3.4B | — |
Shares outstanding 193.9M · Free float 91.3%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.